CROUCH OAK FAMILY PRACTICE — All Prescriptions & Medications — Page 9
Practice Code: H81042 | ADDLESTONE, KT15 2BH
Showing results 401-450 of 617
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Domperidone | 38 | 10.6K | £2.3K | +6.5% ▲ |
| Urea | 38 | 19.8K | £874 | -43.1% ▼ |
| Labetalol hydrochloride | 37 | 2,408 | £311 | +62.9% ▲ |
| Itraconazole | 36 | 1,882 | £830 | +168.3% ▲ |
| Anastrozole | 36 | 2,072 | £887 | -60.5% ▼ |
| Travoprost | 36 | 180 | £345 | -23.6% ▼ |
| Permethrin | 36 | 2,340 | £631 | -4.5% ▼ |
| Pivmecillinam hydrochloride | 35 | 457 | £238 | -33.3% ▼ |
| Alfuzosin hydrochloride | 35 | 2,072 | £424 | -51.1% ▼ |
| Chlorhexidine gluconate | 35 | 20.8K | £379 | +18.5% ▲ |
| 35 | 3,202 | £211 | -73.3% ▼ | |
| 35 | 940 | £6.1K | +174.0% ▲ | |
| Linagliptin/metformin | 34 | 4,088 | £2.3K | +1.0% vs avg |
| Fluorometholone | 34 | 290 | £91 | +136.0% ▲ |
| 34 | 490 | £221 | -21.1% ▼ | |
| Dabigatran etexilate | 33 | 3,304 | £2.6K | -36.3% ▼ |
| Pizotifen malate | 33 | 2,240 | £99 | -60.0% ▼ |
| RtS 2.4 kcal/ml m/sk lower volume, higher protein (0913011) | 33 | 198.5K | £3.9K | -52.8% ▼ |
| Brinzolamide and timolol | 33 | 210 | £279 | -12.7% ▼ |
| Ursodeoxycholic acid | 32 | 5,030 | £1.4K | -51.6% ▼ |
| Glycopyrronium/formoterol | 32 | 46 | £1.4K | +26.5% ▲ |
| Powder preterm infant formula (0913111) | 32 | 88.8K | £1.4K | +100.9% ▲ |
| 32 | 156 | £322 | +247.5% ▲ | |
| Co-amilofruse (Amiloride hydrochloride/frusemide) | 31 | 1,680 | £239 | -10.9% ▼ |
| Olmesartan medoxomil | 31 | 1,932 | £67 | -55.0% ▼ |
| Aclidinium bromide | 31 | 56 | £1.7K | +16.8% ▲ |
| Oxazepam | 31 | 1,218 | £133 | +45.5% ▲ |
| RtS 1.4 - 2 kcal/g dessert style (milk based) (0913011) | 31 | 190.5K | £3.4K | -18.8% ▼ |
| Diclofenac sodium | 31 | 1,628 | £122 | -38.9% ▼ |
| Lurasidone | 30 | 1,178 | £3.2K | +20.2% ▲ |
| Calcium carbonate | 30 | 2,996 | £261 | -54.4% ▼ |
| Diclofenac sodium | 30 | 3,000 | £149 | +182.1% ▲ |
| Amorolfine hydrochloride | 30 | 215 | £257 | +29.9% ▲ |
| 30 | 850 | £4.2K | +16.0% ▲ | |
| Modafinil | 29 | 3,072 | £356 | +39.1% ▲ |
| 29 | 108 | £1.8K | +184.3% ▲ | |
| Sodium picosulfate | 28 | 18.5K | £1.7K | -22.9% ▼ |
| Rotigotine | 28 | 807 | £4.2K | +3.8% ▲ |
| Oxytetracycline | 28 | 2,848 | £1.1K | +8.4% ▲ |
| Quinine bisulfate | 28 | 700 | £126 | -27.9% ▼ |
| Biphasic insulin lispro | 28 | 185 | £1.1K | -34.8% ▼ |
| Fesoterodine fumarate | 28 | 1,456 | £122 | -29.0% ▼ |
| Ipratropium bromide | 28 | 28 | £212 | +72.7% ▲ |
| Diclofenac sodium | 28 | 2,100 | £1.5K | +16.8% ▲ |
| Lidocaine | 28 | 615 | £544 | +143.6% ▲ |
| Hydralazine hydrochloride | 27 | 2,772 | £144 | -36.0% ▼ |
| Oxcarbazepine | 27 | 1,506 | £708 | -3.4% ▼ |
| Magnesium aspartate | 27 | 1,570 | £1.6K | +78.3% ▲ |
| Tafluprost | 27 | 1,290 | £525 | +45.6% ▲ |
| Lacidipine | 26 | 1,456 | £111 | -78.2% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.